Intel Xeon Platinum 9221 Firmware vulnerabilities

21 CVEs affecting Intel Xeon Platinum 9221 Firmware, 0 known to be exploited (CISA KEV), with EPSS scores. Latest: CVE-2022-43505, published 2023-08-11.

More from Intel.

Highest priority

Known exploited (CISA KEV) first, then by EPSS exploit probability.

• CVE-2022-40982, published 2023-08-11. Medium severity, CVSS 6.5. EPSS: 3% chance of exploitation in the next 30 days. Information exposure through microarchitectural state after transient execution in certain vector execution units for some Intel(R) Processors may allow an authenticated user to potentially enable…
• CVE-2018-12207, published 2019-11-14. Medium severity, CVSS 6.5. EPSS: 0.9% chance of exploitation in the next 30 days. Improper invalidation for page table updates by a virtual guest operating system for multiple Intel(R) Processors may allow an authenticated user to potentially enable denial of service of the host…
• CVE-2020-0590, published 2020-11-12. High severity, CVSS 7.8. EPSS: 0.4% chance of exploitation in the next 30 days. Improper input validation in BIOS firmware for some Intel(R) Processors may allow an authenticated user to potentially enable escalation of privilege via local access.
• CVE-2022-26373, published 2022-08-18. Medium severity, CVSS 5.5. EPSS: 0.4% chance of exploitation in the next 30 days. Non-transparent sharing of return predictor targets between contexts in some Intel(R) Processors may allow an authorized user to potentially enable information disclosure via local access.
• CVE-2019-14607, published 2019-12-16. Medium severity, CVSS 5.3. EPSS: 0.3% chance of exploitation in the next 30 days. Improper conditions check in multiple Intel® Processors may allow an authenticated user to potentially enable partial escalation of privilege, denial of service and/or information disclosure via…
• CVE-2021-0124, published 2022-02-09. Medium severity, CVSS 6.6. EPSS: 0.3% chance of exploitation in the next 30 days. Improper access control in the firmware for some Intel(R) Processors may allow a privileged user to potentially enable escalation of privilege via physical access.
• CVE-2021-0156, published 2022-02-09. High severity, CVSS 7.8. EPSS: 0.3% chance of exploitation in the next 30 days. Improper input validation in the firmware for some Intel(R) Processors may allow an authenticated user to potentially enable an escalation of privilege via local access.
• CVE-2021-0117, published 2022-02-09. High severity, CVSS 7.8. EPSS: 0.3% chance of exploitation in the next 30 days. Pointer issues in the firmware for some Intel(R) Processors may allow a privileged user to potentially enable an escalation of privilege via local access.
• CVE-2021-0116, published 2022-02-09. High severity, CVSS 7.8. EPSS: 0.3% chance of exploitation in the next 30 days. Out-of-bounds write in the firmware for some Intel(R) Processors may allow a privileged user to potentially enable an escalation of privilege via local access.
• CVE-2021-0125, published 2022-02-09. Medium severity, CVSS 6.6. EPSS: 0.3% chance of exploitation in the next 30 days. Improper initialization in the firmware for some Intel(R) Processors may allow a privileged user to potentially enable escalation of privilege via physical access.

Latest

• CVE-2022-43505, published 2023-08-11. Medium severity, CVSS 4.4. EPSS: 0.2% chance of exploitation in the next 30 days. Insufficient control flow management in the BIOS firmware for some Intel(R) Processors may allow a privileged user to potentially enable denial of service via local access.
• CVE-2022-32231, published 2023-02-16. Medium severity, CVSS 6.7. EPSS: 0.2% chance of exploitation in the next 30 days. Improper initialization in the BIOS firmware for some Intel(R) Processors may allow a privileged user to potentially enable escalation of privilege via local access.
• CVE-2022-26343, published 2023-02-16. Medium severity, CVSS 6.7. EPSS: 0.2% chance of exploitation in the next 30 days. Improper access control in the BIOS firmware for some Intel(R) Processors may allow a privileged user to potentially enable escalation of privilege via local access.
• CVE-2022-21136, published 2022-05-12. Medium severity, CVSS 5.5. EPSS: 0.3% chance of exploitation in the next 30 days. Improper input validation for some Intel(R) Xeon(R) Processors may allow a privileged user to potentially enable denial of service via local access.
• CVE-2022-21131, published 2022-05-12. Medium severity, CVSS 5.5. EPSS: 0.3% chance of exploitation in the next 30 days. Improper access control for some Intel(R) Xeon(R) Processors may allow an authenticated user to potentially enable information disclosure via local access.
• CVE-2021-33124, published 2022-05-12. Medium severity, CVSS 6.7. EPSS: 0.3% chance of exploitation in the next 30 days. Out-of-bounds write in the BIOS authenticated code module for some Intel(R) Processors may allow a privileged user to potentially enable aescalation of privilege via local access.
• CVE-2021-33123, published 2022-05-12. High severity, CVSS 7.8. EPSS: 0.3% chance of exploitation in the next 30 days. Improper access control in the BIOS authenticated code module for some Intel(R) Processors may allow a privileged user to potentially enable aescalation of privilege via local access.
• CVE-2021-0189, published 2022-05-12. High severity, CVSS 7.8. EPSS: 0.3% chance of exploitation in the next 30 days. Use of out-of-range pointer offset in the BIOS firmware for some Intel(R) Processors may allow a privileged user to potentially enable aescalation of privilege via local access.